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ABSTRACT 
Background: Arterial reservoir-wave analysis (RWA) - a new model of arterial hemodynamics - 
separates arterial wave into reservoir pressure (RP) and excess pressure (XSP). The XSP integral 
(XSPI) has been associated with increased risk of clinical outcomes. The objectives of the 
present study were to examine the determinants of XSPI in a mixed cohort of hemodialysis (HD) 
and peritoneal dialysis (PD) patients, to examine whether dialysis modality, and presence of an 
arteriovenous fistula (AVF) are associated with increased XSPI. 
Method: In a cross-sectional study, 290 subjects (232 HD, and 130 with AVF) underwent 
carotid artery tonometry (calibrated with brachial diastolic and mean blood pressure). The XSPI 
was calculated through RWA using pressure-only algorithms. Logistic regression was used for 
determinants of XSPI above median. Through forward conditional linear regression, we 
examined whether treatment by HD or presence of AVF is associated with higher XSPI. 
Results: Patients with XSPI> median were older, had a higher prevalence of diabetes and 
cardiovascular disease, had a higher body mass index and were more likely to be on HD. After 
adjustment for confounders, HD was associated with a higher risk of higher XSPI (OR=2.39, 
95%CI:1.16-4.98). In a forward conditional linear regression analysis, HD was associated with 
higher XSPI (standardized coefficient: 0.126, P=0.012), but upon incorporation of AVF into the 
model, AVF was associated with higher XSPI (standardized coefficient: 0.130, P=0.008) and HD 
was excluded as a predictor. 
Conclusion: This study suggests that higher XSPI in HD patients is related to the presence of 
AVF. 
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INTRODUCTION 
Patients with end-stage kidney disease are at increased risk of all-cause and cardiovascular 
mortality. 1,2 Among non-traditional cardiovascular risk factors, aortic stiffness and increased 
wave reflection have been proposed to contribute to this increased risk of cardiovascular and 
over-all mortality. 
3,4
   Indeed, it is proposed - by the wave propagation model - that aortic 
stiffness leads to increased augmentation index (enhanced and earlier wave reflection) in the 
ascending aorta, resulting in increased cardiac workload and reduced coronary perfusion 
pressure. However, in an elderly dialysis cohort, aortic stiffness and augmentation index (AIx) 
were not significantly associated with increased risk of death upon adjustment for age and 
comorbidities. 
5,6
 Given that the wave propagation model does not consider the reservoir function 
of the arterial tree, a reservoir-wave approach (RWA) has been proposed to circumvent this 
limitation. 
7-11
 The RWA approach hypothesizes that the measured arterial pressure is the sum of 
a reservoir pressure wave (RP), which accounts for the dynamic storage and release of blood by 
the compliant arteries (the Windkessel effect), and an excess pressure wave (XSP), which is 
responsible for local changes in the pulse waveform. Theoretically, the aortic reservoir pressure 
is the minimum left ventricular work required to generate blood flow into the aorta, whereas the 
excess pressure provides information about the surplus of work performed by left ventricle and is 
believed to be analogous to flow. 
10-13
 
The added value of RWA has been demonstrated in patients with hypertension, in high risk 
patients, in patients with heart failure and in dialysis population. 
14-20
 Indeed, we and others have 
previously shown that higher excess pressure is associated with increase cardiovascular and all-
cause mortality in dialysis population. 19,20 As XSPI is analogous to flow, and creation of an 
arteriovenous fistula (AVF: either native or graft) has been shown to increase stroke volume and 
increased myocardial contractility, we hypothesized that excess pressure should increase after 
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creation of AVF. 
21-23
. Therefore, the aim of the present study was 1) to identify the determinants 
of excess pressure in dialysis patients, 2) to examine whether the dialysis modality has an impact 
on excess pressure, and 3) to examine whether the presence of AVF is associated with a higher 
excess pressure.  
 
METHODS 
Patient population and study design 
In a cross-sectional study we aimed to study the determinants of excess pressure in a cohort of 
end-stage renal disease patients treated by chronic hemodialysis or chronic peritoneal dialysis.  
From August 2006 to June 2014, 328 patients underwent at least one extensive evaluation for 
medical history, laboratory data, pharmacological treatment and hemodynamic parameters of 
arterial stiffness. This cohort of patients was composed of adult patients on chronic dialysis (>3 
months), with single-pool KT/V >1.4 in hemodialysis patients and a weekly KT/V of >1.7 in 
patients on peritoneal dialysis, stable dry weight and blood pressure medication. Patients were 
excluded if they had an acute episode of illness (infection, recent cardiovascular events) or any 
clinical conditions that would hamper hemodynamic measurements (absence of femoral pulse, 
systolic blood pressure of <90 mmHg).  Coronary artery disease was defined as myocardial 
infarction, coronary artery revascularization or ischemic heart disease as shown by either a 
treadmill, echocardiography or thallium stress tests. History of atherosclerotic cardiovascular 
disease was defined by a history of non-hemorrhagic stroke, coronary artery disease, lower 
extremity amputation or revascularization. Hypertension was defined as brachial blood pressure 
≥140/90mm Hg or antihypertensive drug usage. 
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Hemodynamic measurements 
All measurements were performed in the same visit after 15 minutes of rest in a supine position. 
In hemodialysis patients, all assessments were performed prior to their mid-week dialysis 
session. Brachial artery blood pressure (BP) was recorded 6 times, with a 2-minutes interval 
using an automatic oscillometric sphygmomanometer BPM- 100 (BP-Tru, Coquitlam, Canada) 
by an experienced operator who was present in the room. In case of an AVF, measurements were 
performed on the contralateral arm. Immediately after BP measurements, radial and carotid pulse 
wave profiles were sequentially recorded in the same order by applanation tonometry 
(SphygmoCor system, AtCor Medical Pty. Ltd., Sydney, Australia). Three consecutive 
recordings were performed for each site. Central pressure parameters were obtained by radial 
artery tonometry through generalized transfer function from which central systolic pressure (SP), 
diastolic pressure (DP), pulse pressure (PP), and augmentation index adjusted for heart rate of 75 
bpm (AIx@75) were derived after calibration for brachial systolic and diastolic BPs. Carotid 
pressure wave forms were obtained by tonometry after calibration using brachial diastolic and 
mean arterial pressure, which was obtained by integration of the arterial pressure waveform. 
24
 
Immediately after pulse wave recordings, we determined carotid-femoral pulse wave velocity 
(cf-PWV) and carotid-radial pulse wave velocities (cr-PWV) in triplicate by Complior® SP 
(Artech Medical, Pantin - France), using the maximal upstroke algorithm and direct 
measurements as previously described. 
25,26
 We used the ratio of cf-PWV/cr-PWV as a measure 
of arterial stiffness gradient (PWV ratio). 
 
Reservoir-wave parameters were obtained using the pressure wave approach as previously 
described.
14,27
 Reservoir pressure (RP), its integrals (RPI), excess pressure (XSP) and its integral 
(XSPI), diastolic rate constant (DC) and systolic rate constant (SC) were acquired from carotid 
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pressure waveforms. Accordingly, SC is the rate of system filling which is inversely proportional 
to the product of characteristic impedance (Z0) and compliance (C), whereas DC is the rate of 
system emptying, which is inversely proportional to the product of peripheral vascular resistance 
(R) and compliance (C). RP was derived based on pressure alone and XSP was defined as the 
difference between total measured pressure and RP. A reservoir pressure analysis was considered 
valid with RP>0, XSPI>0, a numerical SC and DC, DC>0 and P∞ >0. RP proportion and XSP 
proportion were respectively the ratio of RPI or XSPI to total pressure integral x 100. The 
XSP:RP is the ratio of XSP proportion to RP proportion. Figure 2 summarizes the key 
parameters of RWA of the carotid artery.  
 
Wave separation analysis was conducted to derive central pressure forward (Pf), pressure 
backward (Pb), and reflection magnitude (RM = (100 x Pb)/Pf) and reflection index (RI=(Pb x 
100)/(Pb+Pf)) were calculated. This was performed on the central pressure waveform after 
application of a generalized transfer function on the radial artery pressure waveform. 
28,29
 
 
Biochemical analysis 
All routine laboratory tests were performed on the mid-week hemodialysis session for patients 
on hemodialysis and in the morning in patients on peritoneal dialysis. The PTH was measured 
with the PTH stat assay from Roche diagnostics using two antibodies reactive with epitopes in 
the amino acid regions 26-32 and 37-42 (normal: 15-90 ng/L), and C-reactive protein was 
measured by an immunoturbidimetric method (normal <10 mg/L) as previously described. 25 
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Statistical analysis 
Results were reported as mean ± standard deviation or median [25
th
-75
th
 percentiles] where 
appropriate. To identify the determinants of XSPI, we separated the population according to the 
median value of XSPI. Differences in characteristics parameters between groups were evaluated 
using Fischer’s exact test, Mann-Whitney U or independent Student t tests. To examine if 
dialysis modality was associated with increased risk of high XSPI, we used multivariable logistic 
regression analysis and adjusted for age, diabetes status, cardiovascular disease, mean arterial 
pressure, BMI, heart rate and cf-PWV. After log transformation of XSPI, we used a multiple 
linear regression analysis in a forward conditional manner by using the following parameters as 
independent: age, CVD, diabetes status, BMI, cr-PWV, cf-PWV, PWV ratio, heart rate, mean 
blood pressure. To examine whether any effect of hemodialysis is related to the presence of an 
AVF, we conducted the same regression analysis by adding this information into the list of 
independent parameters. As part of sensitivity analysis MBP was replaced by brachial diastolic 
and then systolic BP, and again with forced entrance of age and CVD into the model. Finally, we 
conducted an additional forward conditional multivariable analysis by restricting our population 
to hemodialysis patients only. We also conducted adjusted model by including clinically 
important parameters into the model (age, CVD, diabetes, dialysis vintage, heart rate, BMI and 
mean blood pressure).  All statistical analyses were performed using IBM SPSS version 25.0 
(SPPS Inc., Chicago, ILL, USA). 
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RESULTS 
From the 328 subjects that were eligible, 38 subjects (12%) were excluded because of 
unavailable or unreliable measurements of carotid pulse waveforms, leaving 290 subjects in the 
study (Figure 1). There were 58 (20%) patients on PD and 232 (80%) on HD. Among patients on 
HD, 130 (56%) had an AVF. Table 1 shows the clinical, biochemical and pharmacological 
characteristics of the subjects. 
 
Determinants of higher excess pressure integral 
Patients with XSPI above median were older and had a higher body mass index, had a higher 
prevalence of diabetes and cardiovascular disease, were treated more frequently by hemodialysis, 
and had a higher rate of aspirin, beta-blockers and calcium channel blockers use (Table 2). As 
expected, patients with higher XSPI had a higher cf-PWV, systolic and pulse pressures, with a 
slightly lower heart rate. Table 2 also shows the detailed hemodynamic parameters obtained 
through wave separation analysis of central pressure waveform after application of generalized 
transfer function of the radial pressure waveform. 
 
Dialysis modality and excess pressure integral 
In multivariable logistic regression analysis (enter mode) adjusted for age, diabetes status, 
cardiovascular disease, mean arterial pressure, BMI, heart rate and cf-PWV, patients on 
hemodialysis had a higher risk of having an XSPI above median (OR= 2.39, 95%CI:1.16-4.98). 
In a forward conditional regression analysis using age, diabetes, CVD, mean arterial pressure, 
heart rate, cf-PWV, cr-PWV, PWV ratio, type of dialysis and BMI, treatment by hemodialysis 
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was independently associated with a higher XSPI (Table 3: Model 1). Figure 3A shows that 
XSPI is higher in HD patients after adjustment for PWV ratio, heart rate, diabetes status, MBP 
and BMI.  As part of sensitivity analysis, we used diastolic blood pressure instead of mean blood 
pressure (Table 3: Model 2), which still showed that hemodialysis was associated with increased 
excess pressure. In further sensitivity analysis, where MBP was replaced by brachial systolic 
blood pressure, hemodialysis was not independently associated with increased excess pressure 
(Table 3: Model 3). 
 
Arteriovenous fistula and excess pressure integral 
Since excess pressure integral was higher in hemodialysis patients (even after adjustment for 
potential confounders), we examined to see whether this difference was due to presence of an 
AVF. Indeed, by means of a forward conditional regression analysis we added presence of an 
AVF to the same model (i.e. a model which included age, diabetes, CVD, mean arterial pressure, 
heart rate, cf-PWV, cr-PWV, PWV ratio, type of dialysis, and BMI). As shown in Table 3, the 
addition of AVF into the analysis, resulted in a model where AVF was associated with a higher 
excess pressure and the dialysis modality was no longer statistically significant (Table 3: Model 
4). Figure 3B shows that XSPI is higher in patients with AVF after adjustment for PWV ratio, 
heart rate, diabetes status, MBP and BMI. Further sensitivity analysis was performed by 
replacing MBP by brachial diastolic and systolic blood pressure (Table 3: Model 5 and 6 
respectively), and both consistently showed that AVF was independently associated with higher 
excess pressure. In addition, we forced entered age and CVD (enter mode), variables which were 
eliminated from the final forward conditional model, and the results pertaining to the association 
of AVF and excess pressure remained similar (Standardized coefficient: 0.126; P=0.011).  
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Finally, as part of sensitivity analysis, we excluded patients with peritoneal dialysis and 
conducted the analysis only on HD patients with and without fistula. In patients on HD without 
AVF the median number of antihypertensive drugs was higher (2 [1-3]) compared to HD patients 
with AVF (1 [0 -1], P=0.005). Using a similar forward conditional approach, there was a signal 
that an AVF was associated with a higher XSPI (standardized coefficient = 0.096, P=0.091), but 
it failed to reach a statistical level of significance (Figure 3C). 
 
Dialysis modality, AVF and wave reflection 
Based on wave-propagation model, as part of sensitivity analysis, we examined the impact of 
dialysis modality and AVF on heart rate adjusted augmentation index using the same variables as 
for excess pressure. In this model, only age, cardiovascular disease and mean arterial pressure 
were associated with higher AIx@75, but dialysis modality and AVF were excluded as important 
predictors of AIx@75. 
In a similar manner, we examined the impact of dialysis modality and AVF on reflection 
magnitude and reflection index. In these models, only age, heart rate, cardiovascular disease and 
mean arterial pressure were associated with reflection magnitude and reflection index, but 
dialysis modality and AVF were excluded as significant predictors. 
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DISCUSSION 
In this cross-sectional analysis of prevalent dialysis population, we showed that comorbid 
conditions were associated with increased excess pressure. Moreover, hemodialysis patients had 
a higher excess pressure after adjustment for comorbid conditions, but this increase in excess 
pressure was mostly related to the presence of an arteriovenous fistula after adjustment for 
confounding factors.   
RWA is a new model of arterial pressure that incorporates the reservoir function with wave-
propagation. The RWA approach is based on the assumption that the measured arterial pressure 
is the sum of a reservoir pressure wave, which results from the dynamic storage and release of 
blood by the compliant vessel, and an excess pressure wave, which is responsible for local 
changes in the pulse waveform. Theoretically, the aortic reservoir pressure is the minimum left 
ventricular work required to generate blood flow into the aorta, whereas the excess pressure - 
analogous to flow - provides information about the surplus of work performed by left ventricle. 
10-13
 Given that previous studies have shown increased stroke volume and increased myocardial 
contractility after a creation of AVF, it is reasonable to expect that excess pressure should 
increase after creation of AVF. 
21-23
  
AVF is the vascular access of choice for hemodialysis. 
30
 In a recent meta-analysis, it was shown 
that creation of dialysis AVF reduced SBP, DBP and MBP by estimated average of 8.7, 5.9 and 
6.6-mm Hg respectively. 31 This observation is also in line with the use of ROX arteriovenous 
coupler, which is used to create an AVF between distal external iliac vein and artery, and which 
has been shown to reduce the ambulatory SBP by an average of 13.5 mm Hg in a group of 
patients with resistant hypertension 
32
. Indeed, epidemiological observational studies using 
administrative databases show that hemodialysis with an AVF gives a better survival advantage 
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over the use of central venous catheters. 
33-36
 However, this view has recently been challenged as 
the survival advantage of native AVF is more likely related to general better health of patients 
referred for AVF creation and who develop a functioning AVF. 
37-39
 While it could be proposed 
that AVF may have potential protective effects through reduction in blood pressure, AVF also 
bypasses part of the blood flow that is destined to organ perfusion, increases heart rate, 
myocardial contractility and stroke volume and cardiac output. 
21-23,40-42
 Given the association 
between increased XSPI and clinical outcomes, this reduction in blood pressure by AVF may 
potentially have adverse effects through disturbances in flow dynamics. 
18-20
 In our study, 
restricting the analysis to HD patients, after adjustment for other determinants of XSPI, subjects 
with AVF had a numerically higher XSPI. While this difference failed to reach the statistical 
level of significance (P=0.091), one would have expected a lower XSPI in patients with AVF 
because of a better general state of vascular health in this population. Indeed, patients with AVF 
may have a strong selection bias because not all subjects develop a functioning AVF due to 
cumulative stress of co-morbidities on peripheral arteries and veins. These cumulative co-
morbidities lead to both arterial disease (stenosis and calcification) and scarcity of veins that 
results from multiple venous punctures required over the life course of chronic disease. We know 
from our previous study that high XSPI is associated with increased risk of both cardiovascular 
and overall mortality. Accordingly, one would have expected to have a higher XSPI in patients 
without AVF, who are generally sicker.  Therefore, the association of high XSPI with AVF are 
more likely related to changes in flow dynamics due to AVF. 
The study has several strengths as it provides detailed analysis of a large sample size using 
RWA, wave separation analysis, vascular stiffness, and the use of various comorbidities and 
statistical procedures to perform various sensitivity analysis, which consistently show that AVF 
is associated with increased XSPI. There are also limitations that need to be mentioned. First, 
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while physiologically appealing and various sensitivity analyses support the robustness of our 
findings, the study only shows an association between AVF and XSPI and the causality is not 
demonstrated by this study. Second, we do not have any information regarding the extent of 
access blood flow at time of vascular assessment. Third, the pressure-only approach for 
calculation of reservoir-pressure waves assumes that the resultant excess pressure is proportional 
to the volume flow rate out of the left ventricle. However, the validation of this assumption in 
humans has recently been performed by Michail and colleagues. 
43
  
In conclusion, our study shows that patients on HD have higher excess pressure that is mainly 
related to the presence of an AVF. These observations need to be confirmed in dialysis patients 
by directly examining excess pressure before and after creation of an AVF, as the potential 
benefits of an AVF may be outweighed by increase in excess pressure. 
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FIGURE LEGENDS 
Figure 1: Study flow chart. Study flowchart shows the number of patients excluded for lack of 
carotid pressure waveform and unreliable reservoir-wave analysis (RWA), the number of 
patients on hemodialysis (HD), peritoneal dialysis (PD), with and without arteriovenous fistula 
(AVF). 
Figure 2: Reservoir-wave parameters. The panel shows artery pressure waveform (⸺○⸺) 
decomposed into reservoir pressure (⸺) and excess pressure waveforms (⸺●⸺), systolic and 
diastolic constant rates.  
Figure 3: Adjusted excess pressure integral according to dialysis modality and 
arteriovenous fistula. Panel A shows a higher level of adjusted excess pressure integral (XSPI) 
in patients on hemodialysis (HD) compared to patients on peritoneal dialysis (PD). Panel B 
shows a higher adjusted XSPI in patients with arteriovenous fistula (AVF) compared to dialysis 
patients without AVF. Panel C shows the adjusted XSPI in HD patients with or without AVF 
using a forward conditional approach. Bars represent 95% confidence intervals. 
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Table 1: Demographic, biochemical and pharmacological characteristics 
Parameter N=290 
Age (y) 64.8 ± 14.9 
Male 173 (60) 
Diabetes 124 (43) 
CVD 151 (52) 
Smoking 115 (40) 
BMI (Kg/m
2
) 27.2 ± 5.5 
Weight (Kg) 74.0 ± 16.6 
Peritoneal dialysis 58 (20) 
Hemodialysis access  
Arteriovenous fistula* 130 (56) 
Catheter* 102 (44) 
Dialysis vintage (y) 1.5 [0.5-3.3] 
stdKt/v 2.28 ± 0.26 
Biochemical  
Hb (g/l) 113.0 ± 11.6 
Albumin (g/l) 37.6 ± 3.5 
Calcium (mmo/l) 2.20 ± 0.17 
Phosphate (mmol/) 1.51 ± 0.38 
PTH (ng/l) 285 [187-450] 
Cholesterol (mmol/) 3.85 ± 0.98 
TG (mmol/) 1.94 ± 1.08 
CRP (mg/L) 6.2 [2.5-14.4] 
Medication  
ASA 185 (64) 
Warfarin 54 (19) 
Statin 182 (63) 
ACEi/ARB 131 (45) 
B-blockers 167 (58) 
Calcium channel blockers 103 (36) 
Diuretics 132 (46) 
Nitrates 49 (17) 
Values are mean±SD, n (%), or median [25
th
-75
th
 percentile] 
CVD: cardiovascular disease, std Kt/V: standardized Kt/V, ACEi: angiotensin-converting-
enzyme inhibitor, ARB: angiotensin receptor blockers, ASA: acetylsalicylic acid, CRP: C-
reactive protein, Hb: hemoglobin, PTH: parathyroid hormone, TG: triglyceride.  
*: percentage based on hemodialysis patients only. 
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Table 2: Clinical and hemodynamic parameters according to excess pressure integral 
 Excess pressure integral  
 Below median 
(n=145) 
Above median 
(n=145) 
P 
Clinical characteristics    
Age (y) 60.7 ± 16.0 69.0 ± 12.4 <0.001 
Male 85 (59) 88 (61) 0.811 
Cardiovascular disease 53 (37) 98 (68) <0.001 
Diabetes 40 (28) 88 (58) <0.001 
Smoking 65 (45) 50 (34) 0.093 
Dialysis vintage (y) 1.7 [0.5 – 3.7] 1.2 [0.5-3.2] 0.281 
Weight (kg) 72.9 ± 15.6 75.1 ± 17.6 0.254 
BMI (kg/m
2
) 26.4 ± 4.9 28.0 ± 5.9 0.014 
Hemodialysis 106 (73) 126 (87) 0.005 
Arteriovenous Fistula 60 (41) 70 (48) 0.288 
HR 71.2± 10.2 65.0± 10.0 <0.001 
Brachial BP    
SBP (mmHg) 123.0 ± 20.0 142.1± 26.5 <0.001 
DBP (mmHg) 73.9 ± 12.7 68.2 ± 12.8 <0.001 
MBP (mm Hg) 90.9 ± 15.0 93.5 ±17.7 0.180 
Carotid BP    
SBP (mmHg) 114.6 ± 20.7 135.3 ± 27.0 <0.001 
DBP (mmHg) 73.6 ± 12.8 67.3 ± 13.0 <0.001 
PP (mmHg) 41.0 ± 14.3 68.0 ± 20.5 <0.001 
Carotid Reservoir-Wave    
XSPI (kpa.s) 0.26 [0.20-0.31] 0.56 [0.45-0.74] <0.001 
XSP (mm Hg) 13.8 ± 3.1 26.9 ± 9.0 <0.001 
Time at XSP (ms) 41.0 ± 14.3 68.0 ± 20.5 <0.001 
RPI (kpa.s) 1.38[1.16-1.85] 2.29 [1.63-2.94] <0.001 
RP (mm Hg) 33.3 ± 12.9 50.2 ± 19.0 <0.001 
Time at RP (ms) 30.6 ± 3.6 33.0 ± 3.9 <0.001 
Proportion of XSPI (%)  15.1 ± 4.8 22.4 ± 8.8 <0.001 
XSPI:RPI 0.18 ± 0.07 0.31 ± 0.17 <0.001 
Systolic constant rate (x10
-2
) 19.8 [15.8-25.5] 16.6 [10.8-21.4] <0.001 
Diastolic constant rate (x10
-2
) 2.9 [2.1-4.4] 3.4 [2.8-4.2] 0.041 
Pulse wave velocity    
cf-PWV (m/s) 12.6 ± 3.9 14.8 ± 3.9 <0.001 
cr-PWV (m/s) 9.1± 1.6 8.6 ± 1.8 0.031 
PWV ratio 1.42 ± 0.49 1.76 ± 0.49 <0.001 
Central wave separation (GTF)    
AIx@75 (%) 24.1 ± 11.6 28.7 ± 9.2 <0.001 
Forward wave (mmHg) 28.0 ±8.3 42.9 ± 11.8 <0.001 
Backward wave (mmHg) 14.0 ± 5.4 23.3 ± 8.0 <0.001 
Reflection Magnitude 49.6 ± 9.2 53.7 ± 9.4 <0.001 
Reflection Index 32.9 ± 4.2 34.7 ± 3.7 <0.001 
Medication    
ASA 76 (52) 109 (75) <0.001 
Warfarin 23 (16) 31 (21) 0.291 
ACEi/ARB 57 (39) 74 (51) 0.059 
Beta-Blockers 73 (50) 94 (65) 0.017 
Calcium channel blockers 37 (26) 66 (46) 0.001 
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Nitrates 19 (13) 30 (21) 0.116 
Diuretics 63 (43) 69 (48) 0.556 
Statin 88 (61) 94 (65) 0.544 
Value are mean ± SD, n (%) or median [25th-75th percentile].  P value obtained by Fisher’s 
exact test, Student t-test or Mann-Whitney U tests as appropriate.  
RP, reservoir pressure; RPI, reservoir pressure integral; XSP, excess pressure; XSPI, excess 
pressure integral; cf-PWV, carotid-femoral pulse wave velocity; cr-PWV, carotid-radial pulse 
wave velocity; PWV ratio, ratio of cf-PWV-to-cr-PWV; SBP, systolic blood pressure; DBP, 
diastolic blood pressure; MBP, mean blood pressure; PP, pulse pressure; ACEi, angiotensin-
converting-enzyme inhibitor; ARB, angiotensin receptor blockers; ASA, acetylsalicylic acid, 
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Table 3: Determinants of excess pressure integral according to dialysis modality and 
presence of arteriovenous fistula 
 Without AVF in the model   With AVF in the model 
Parameters 
Standardized 
coefficient 
P 
Adjusted 
R2 
 Parameters Standardized 
coefficient 
P Adjusted 
R2 
Model 1   0.315  Model 4   0.316 
PWV ratio 0.294 <0.001   PWV ratio 0.304 <0.001  
Heart rate -0.282 <0.001   Heart rate -0.288 <0.001  
Diabetes 0.203 <0.001   Diabetes 0.222 <0.001  
MBP 0.176 <0.001   MBP 0.172 0.001  
Hemodialysis 0.126 0.012   Hemodialysis* - -  
BMI 0.108 0.036   BMI 0.101 0.050  
   
 
 AVF 0.130 0.008 
 
 
Model 2   0.282  Model 5   0.285 
PWV ratio 0.280 <0.001   PWV ratio 0.289 <0.001  
Heart rate -0.264 <0.001   Heart rate -0.269 <0.001  
Diabetes 0.247 <0.001   Diabetes 0.261 <0.001  
Hemodialysis 0.100 0.050   Hemodialysis* - -  
DBP* - -   DBP* - -  
   
 
 AVF 0.114 0.023 
 
 
Model 3   0.398  Model 6   0.407 
SBP 0.409 <0.001   SBP 0.406 <0.001  
cr-PWV -0.179 0.002   cr-PWV -0.170 0.003  
Heart rate -0.235 <0.001   Heart Rate -0.239 <0.001  
Diabetes 0.203 <0.001   Diabetes 0.201 <0.001  
PWV ratio 0.142 0.014   PWV ratio 0.155 0.007  
Hemodialysis* - -   Hemodialysis* - -  
     AVF 0.109 0.018  
Parameters presented in the table are those that were included in the final model. 
 * no value for standardized coefficient provided as the parameters was not included in the final model. 
Model 1 was built using forward conditional regression analysis by using age, diabetes status, 
cardiovascular disease, body mass index (BMI), heart rate, mean blood pressure (MBP), Dialysis 
modality, carotid-femoral pulse wave velocity (PWV), carotid-radial PWV, the ratio of cf-PWV to cr-
PWV (PWV ratio). 
Model 2: Same as model 1 except MBP was replaced by brachial Diastolic Blood Pressure 
Model 3: Same as model 1 except MBP was replaced by brachial Systolic Blood Pressure  
Model 4: Same as in Model 1 + presence of arteriovenous fistulae (AVF) 
Model 5: Same as in Model 2 + presence of arteriovenous fistulae (AVF) 
Model 6: Same as in Model 2 + presence of arteriovenous fistulae (AVF) 
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Figure 1 
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Figure 2 
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Figure 3 
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